Emerging strategies for drug development in motor neuron disease

Bibliography

• JUERGENS SM, KURLANDLT, OKAZAKI H, MULDER DW: ALS in Rochester, Minnesota. Neurology (1980) 30(5):463–470.
   PubMed Web of Science ®Google Scholar
• SIDDIQUE T, FIGLEWICZ DA, PERICAK-VANCE MA et al.: Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 2 land evidence of genetic-locus heterogeneity. N Engl. I Med. (1991) 324(20):1381–1384.
   PubMed Web of Science ®Google Scholar
• ROSEN DR, SIDDIQUE T, PATTERSON D: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 362(6415):59–62.
   PubMed Web of Science ®Google Scholar
• •This was the first publication identifying a specific genetic cause of ALS in some families.
   Google Scholar
• GURNEY ME, PU H, CHIU AY et al.: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 264:1772–1775.
   PubMed Web of Science ®Google Scholar
• •This was the first publication of a transgenic model of ALS and the first true animal model of the disease.
   Google Scholar
• ROTHSTEIN JD, UN, J. DYKES-HOBERG M, KUNCL RW: Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Nati Acad. Sci. USA (1993) 90:6591–6595.
   Google Scholar
• FIGLEWICZ DA, DONG L, MLODZIENSKI M, TURCOTTE JC: Culture models of neurodegenerative disease. Ann. NY Acad. Sci. (2000) 919:106–118.
   PubMedGoogle Scholar
• •This reference describes the utility of tissue culture models in studying neuro-degenerative diseases. Specifically, it discusses their development of hybrid cell lines that allow study of the specific effects of the genetic mutations at the cellular level.
   Google Scholar
• ROTHSTEIN JD, TSAI G, KUNCL RW et al.: Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol (1990) 28:18–25.
   PubMed Web of Science ®Google Scholar
• ROTHSTEIN JD, MARTIN LJ, KUNCL RW: Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl. J. Med. (1992) 22:1464–1468.
   Web of Science ®Google Scholar
• SHAW PJ, CHINNERY[1H] D-Aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: A quantitative autoradiographic study. Brain Res. (1994) 655:195–201.
   PubMed Web of Science ®Google Scholar
• ROTHSTEIN JD, VAN KAMMEN M, LEVEY Al, MARTIN LJ, KUNCL RW: Selective loss of glial glutamate transporter GUT-1 in amyotrophic lateral sclerosis. Ann. Neurol (1995) 38:73–84.
   PubMed Web of Science ®Google Scholar
• •This publication was the first to identify the loss of the astrocytic glutamate transporter in ALS, providing further evidence of the association between glutamate excitotoxicity and the pathogenesis of ALS.
   Google Scholar
• BENSIMON G, LACOMBLEZ L, MEININGER V: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl. J. Med. (1994) 330:585–591.
   PubMed Web of Science ®Google Scholar
• MILLER RG, BOUCHARD JP, DUQUETTE P et al.: Clinical trials of riluzole in patients with ALS. Neurology (1996) 47\(Suppl. 2):S86–S92.
   Google Scholar
• RADUNOVIC A, LEIGH PN: Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: Correlation between genotype and clinical features. J. Neurol Neurosurg. Psychiatry(1996) 61:565–572.
   PubMed Web of Science ®Google Scholar
• TU P-H, RAJU P, ROBINSON KA, GURNEY ME, TROJANOWSKI JQ, LEE VM-Y: Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Nat. Acad. Sci. USA (1996) 93:3155–3160.
   PubMed Web of Science ®Google Scholar
• WONG PC, PARDO CA, BORCHELT et al.: An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron (1995) 14:1105–1116.
   PubMed Web of Science ®Google Scholar
• KONG J, XU Z: Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. j Neurosci. (1998) 18:3241–3250.
   PubMed Web of Science ®Google Scholar
• ROTHSTEIN JD, DYKES-HOBERG M, PARDO CA: Knockout of glutamate transporters reveals a major role for astrogfial transport in excitotoxicity and clearance of glutamate. Neuron (1996) 16:675–686.
   PubMed Web of Science ®Google Scholar
• DAL CANTO MC, GURNEY ME: Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol (1994) 145:1271–1279.
   PubMed Web of Science ®Google Scholar
• DAL CANTO MC, GURNEY M: Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res. (1995) 676:25–40.
   PubMed Web of Science ®Google Scholar
• HALL ED, ANDRUS PK, OOSTVEEN JA, FLECK TJ, GURNEY ME: Relationship of oxygen radical-induced lipid perwddative damage to disease onset and progression in a transgenic model of familial ALS. Neurosci. Res. (1998) 53:66–77.
   Web of Science ®Google Scholar
• LIU DX, WEN J, LIU J, LI LP: The roles offree radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J. (1999) 13:2318–2328.
   PubMed Web of Science ®Google Scholar
• COOKSON MR, SHAW PJ: Oxidative stress and motor neurone disease. Brain Pathol (1999) 9:165–186.
   PubMed Web of Science ®Google Scholar
• CROW JP, SAMPSON JB, ZHUANG Y, THOMPSON JA, BECKMAN JS: Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. Neurochein. (1997) 69:1936–1944.
   PubMed Web of Science ®Google Scholar
• •This publication identifies potential toxic functions of the mutant SOD. The increased formation of peroxynitrite leads to multiple detrimental downstream effects.
   Google Scholar
• ESTEVEZ AG, CROW JP, SAMPSON JB et al.: Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science (1999) 286:2498–2500.
   PubMed Web of Science ®Google Scholar
• ABE K, PAN L-H, WATANABE M, KONNO H, KATO T, ITOYAMA Y: Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res. (1997) 19:124–128.
   PubMed Web of Science ®Google Scholar
• BEAL MF, FERRANTE RJ, BROWNE SE, MATTHEWS RT, KOWALL NW, BROWN RH, JR: Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol (1997) 42:644–654.
   PubMed Web of Science ®Google Scholar
• TOHGI H, ABET, YAMAZAKI K, MURATA T, ISHIZAKI E, ISOBE C: Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol (1999) 46:129–131.
   PubMed Web of Science ®Google Scholar
• BRUIJN LI, BEAL MF, BECHER MW et al.: Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-finked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA (1997) 94:7606–7611.
   PubMed Web of Science ®Google Scholar
• PODUSLO JF, WHELAN, SL, CURRAN GL, WENGENACK TM: Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics. Ann. Neurol (2000) 48:943-947. This publication likewise identifies potential toxic functions of the mutant SOD. The potentiation of free radical clearance reduces the toxicity of the mutation.
   Google Scholar
• BOWLING AC, SCHULZ JB, BROWN RH, JR, BEAL MF: Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. Neurochein. (1993) 61:2322–2325.
   PubMed Web of Science ®Google Scholar
• SHAW PJ, INCE PG, FALKOUS G, MANTLE D: Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol (1995) 38:691–695.
   PubMed Web of Science ®Google Scholar
• GURNEY ME, CUTTING FB, ZHAI P etal.: Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familiar amyotrophic lateral sclerosis. Ann. Neurol (1996) 39:147–157.
   Google Scholar
• REIDER CR, PAULSON GW: Lou Gehrig and amyotrophic lateral sclerosis. Is vitamin E to be revisited? Arch. Neurol (1997) 54:527–528.
   PubMed Web of Science ®Google Scholar
• ANNESER JM, HORSTMANN S, VVEYDT P, BORASIO GD: Activation of metabotropic glutamate receptors delays apoptosis of chick embryonic motor neurons in vitro. Neuroreport (1998) 9(9):2039–2043.
   PubMed Web of Science ®Google Scholar
• RUSSELL JW, SULLIVAN KA, WINDEBANK AJ, HERRMANN DN, FELDMAN EL: Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis. (1999) 6:347–363.
   PubMed Web of Science ®Google Scholar
• GHADGE GD, LEE JP, BIND OKAS VP et al.: Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection. J. Neurosci. (1997) 17:8756–8766.
   Google Scholar
• MIGHELI A, ATZORI C, PIVA R et al.: Lack of apoptosis in mice with ALS. Nat. Med. (1999) 5:966–967.
   PubMed Web of Science ®Google Scholar
• ROTHSTEIN JD, BRISTOL LA, HOSLER B, BROWN RH, KUNCL RW: Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Nat. Acad. Sci. USA (1994) 91(10):4155–4159.
   PubMed Web of Science ®Google Scholar
• YOSHIYAMA Y, YAMADA T, ASANUMA K, ASAHI T: Apoptosis related antigen, Lei' and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol (1994) 88:207–211.
   PubMed Web of Science ®Google Scholar
• MARTIN LJ: Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. I Neuropathol Exp. Neurol (1999) 58:459–471.
   PubMed Web of Science ®Google Scholar
• BERGE, MM, KOPP N, VITAL C., RED, B, AYMARD M, LINA B: Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology (2001) 54:20–25.
   Web of Science ®Google Scholar
• GIRAUD P, BEAULINEUZ F, ONO S, SHIMIZU N, CHAZOT G, LINA B: Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients. Neurology (2001) 56: 1777–1778.
   PubMed Web of Science ®Google Scholar
• ANSERVIN CF: Treatment of ALS with Pleconaril. Neurology (2001) 56:691–692.
   PubMed Web of Science ®Google Scholar
• ANONYMOUS: A double-blind placebo-controlled clinical trial of subcutaneous recombiant human cilary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology (1996) 46(5):1244–1249.
   Google Scholar
• MILLER, RG, PETAJAN, JH, BRYAN WW et al.: A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factors in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann. Neurol (1996) 39(2):256–260.
   PubMed Web of Science ®Google Scholar
• ANONYMOUS: A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology (1999) 52(7):1427–1433.
   Google Scholar
• LAI EC, FELICE KJ, FESTOFF BW etal.: Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF- I Study Group. Neurology (1997) 49(6):1621–1630.
   Google Scholar
• BORASIO GD, ROBBERECHT W, LEIGH, PN et al.: Aplacebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/ IGF-I Study Group. Neurology (1998) 51(2):583–586.
   Google Scholar
• GURNEY ME, FLECK TJ, HIMES CS etal.: Riluzole preserves motor function in a transgenic model of familiar amyotrophic lateral sclerosis. Neurology (1998) 50(1):62–66.
   Google Scholar